Literature DB >> 18774731

Recent advances in colorectal cancer genetics and diagnostics.

Peh Yean Cheah1.   

Abstract

Colorectal cancer (CRC) is one of the most prevalent cancers and leading cause of cancer mortality worldwide. It is also one of the most curable cancers if detected early. This review classifies the diverse disease subtypes using various parameters including phenotypes of the polyps and describes how recent advances in genetics have impacted on disease diagnostics. For familial syndromes, the discovery of initiating mutations in the germline made personalized medicine a reality. A model linking the main tumorigenesis (Wnt/TGF-beta-BMP/LKB-1/PI3K-AKT) pathways and a strategy for gene testing are proposed. For sporadic CRC, high throughput technology has enabled the discovery of susceptibility loci that increased CRC risk. The ramifications of screening the population for susceptibility loci are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18774731     DOI: 10.1016/j.critrevonc.2008.08.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  16 in total

1.  The classification of intestinal polyposis.

Authors:  Peh Yean Cheah; Kiat Hon Lim; Poh Koon Koh; Choong Leong Tang
Journal:  Nat Genet       Date:  2013-01       Impact factor: 38.330

Review 2.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes.

Authors:  Hongjuan He; Lei Lei; Erfei Chen; Xiaona Xu; Lili Wang; Junqiang Pan; Fangfang Yang; Min Wang; Jing Dong; Jin Yang
Journal:  Cancer Biol Ther       Date:  2017-05-11       Impact factor: 4.742

4.  Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Hansjuerg Alder; Stefano Volinia; Dominique Delmas; Norbert Latruffe; Carlo M Croce
Journal:  Biochem Pharmacol       Date:  2010-07-15       Impact factor: 5.858

5.  Effects of dual modified resistant indica rice starch on azoxymethane-induced incipient colon cancer in mice.

Authors:  Huaibo Yuan; Xiping Zhu; Deyi Chen; Wenjuan Wang; Shaohua Meng; Junhui Wang
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

Review 6.  Wnt modulators in the biotech pipeline.

Authors:  Jean-Philippe Rey; Debra L Ellies
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

7.  Identification of Rho GTPase activating protein 6 isoform 1 variant as a new molecular marker in human colorectal tumors.

Authors:  Fengjie Guo; Yan Liu; Jian Huang; Yuehui Li; Guohua Zhou; Di Wang; Yalin Li; Jiajia Wang; Pingli Xie; Guancheng Li
Journal:  Pathol Oncol Res       Date:  2009-12-04       Impact factor: 3.201

Review 8.  Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis.

Authors:  Yun Tian; Yi Li; Zhenhua Hu; Daqing Wang; Xiyang Sun; Changshan Ren
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

9.  Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population.

Authors:  Fen-Xia Li; Xue-Xi Yang; Ni-Ya Hu; Hong-Yan Du; Qiang Ma; Ming Li
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

10.  Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.

Authors:  Ian Teng; Allan Spigelman
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.